17 results
8-K
EX-4.3
SABS
SAB Biotherapeutics Inc
2 Oct 23
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
4:10pm
8-K
EX-4.1
SABS
SAB Biotherapeutics Inc
2 Oct 23
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
4:10pm
8-K
EX-4.2
SABS
SAB Biotherapeutics Inc
2 Oct 23
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
4:10pm
10-Q
2023 Q1
EX-4.1
SABS
SAB Biotherapeutics Inc
Quarterly report
15 May 23
4:50pm
S-3
EX-4.3
SABS
SAB Biotherapeutics Inc
Shelf registration
9 May 23
4:13pm
8-K
EX-4.1
by9 jyebcylbjf7p15
12 Dec 22
SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock
9:07am
8-K
EX-4.2
pto9tiuo
12 Dec 22
SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock
9:07am
10-K
EX-4.1
rfu7yzt1c9wuivie
2 Apr 21
Annual report
4:57pm
8-K
EX-4.1
aosynenc3nl
12 Jan 21
Big Cypress Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
4:10pm
S-1/A
EX-4.2
1vgxme
4 Jan 21
IPO registration (amended)
5:20pm
S-1/A
EX-4.4
4tnar8nvna81xim2
4 Jan 21
IPO registration (amended)
5:20pm
S-1/A
EX-4.1
w4hedzzw11xnavigff
4 Jan 21
IPO registration (amended)
5:20pm
S-1/A
EX-4.3
tj70si5gefi
4 Jan 21
IPO registration (amended)
5:20pm
- Prev
- 1
- Next